Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/all.15382 | DOI Listing |
Publication Analysis
Top Keywords
relight two-year
4
two-year real-life
4
real-life study
4
study mepolizumab
4
mepolizumab patients
4
patients severe
4
severe eosinophilic
4
eosinophilic asthma
4
asthma greece
4
greece evaluating
4
Similar Publications
RELIght: A two-year REal-LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: Evaluating the multiple components of response.
Allergy
September 2022
2nd Respiratory Department, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!